These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7867309)

  • 21. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.
    Colombo AL; Barchiesi F; McGough DA; Rinaldi MG
    J Clin Microbiol; 1995 Mar; 33(3):535-40. PubMed ID: 7751353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
    Linares MJ; Charriel G; Solís F; Casal M
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):493-7. PubMed ID: 14572382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole.
    Sewell DL; Pfaller MA; Barry AL
    J Clin Microbiol; 1994 Sep; 32(9):2099-102. PubMed ID: 7814531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter evaluation of the new Vitek 2 yeast susceptibility test using new CLSI clinical breakpoints for fluconazole.
    Pfaller MA; Diekema DJ; Procop GW; Wiederhold NP
    J Clin Microbiol; 2014 Jun; 52(6):2126-30. PubMed ID: 24719450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression analysis and categorical agreement of fluconazole disk zone diameters and minimum inhibitory concentration by broth microdilution of clinical isolates of Candida.
    Aggarwal P; Kashyap B
    J Mycol Med; 2017 Jun; 27(2):220-226. PubMed ID: 28363817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antifungal susceptibility of yeasts by Etest. Comparison of 3 media].
    Tapia C; León E; Palavecino E
    Rev Med Chil; 2003 Mar; 131(3):299-302. PubMed ID: 12790079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests.
    Espinel-Ingroff A; Kerkering TM; Goldson PR; Shadomy S
    J Clin Microbiol; 1991 Jun; 29(6):1089-94. PubMed ID: 1864923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans.
    Espinel-Ingroff A; Rodríguez-Tudela JL; Martínez-Suárez JV
    J Clin Microbiol; 1995 Dec; 33(12):3154-8. PubMed ID: 8586692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients.
    Jessup CJ; Pfaller MA; Messer SA; Zhang J; Tumberland M; Mbidde EK; Ghannoum MA
    J Clin Microbiol; 1998 Oct; 36(10):2874-6. PubMed ID: 9738036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
    Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
    Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans.
    Pfaller MA; Grant C; Morthland V; Rhine-Chalberg J
    J Clin Microbiol; 1994 Feb; 32(2):506-9. PubMed ID: 8150963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients.
    Lombardi G; Gramegna G; Cavanna C; Michelone G
    Microbiologica; 1990 Jul; 13(3):201-6. PubMed ID: 2273982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections.
    Berenguer J; Fernández-Baca V; Sánchez R; Bouza E
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):362-5. PubMed ID: 7649205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates].
    Dalyan Cilo B; Topaç T; Ağca H; Sağlam S; Efe K; Ener B
    Mikrobiyol Bul; 2018 Jan; 52(1):35-48. PubMed ID: 29642828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.
    Pfaller MA; Messer SA; Boyken L; Hollis RJ; Rice C; Tendolkar S; Diekema DJ
    Diagn Microbiol Infect Dis; 2004 Mar; 48(3):201-5. PubMed ID: 15023430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.
    Espinel-Ingroff A; Kish CW; Kerkering TM; Fromtling RA; Bartizal K; Galgiani JN; Villareal K; Pfaller MA; Gerarden T; Rinaldi MG
    J Clin Microbiol; 1992 Dec; 30(12):3138-45. PubMed ID: 1452697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
    Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):37-40. PubMed ID: 23870164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans.
    Arthington-Skaggs BA; Jradi H; Desai T; Morrison CJ
    J Clin Microbiol; 1999 Oct; 37(10):3332-7. PubMed ID: 10488201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp.
    Del Poeta M; Bixel AS; Barchiesi F; Tidwell RR; Boykin D; Scalise G; Perfect JR
    J Antimicrob Chemother; 1999 Aug; 44(2):223-8. PubMed ID: 10473229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.